APN News

  • Monday, January, 2021| Today's Market | Current Time: 06:04:12
  • Sigo eVentures Launches India’s First Alternative Medicine Website

    New Delhi:  Sigo eVentures Pvt. Ltd. has announced the launch of www.naturallyhealthy.in, a website that will be India’s most complete guide to alternative medicine. It will also give users access to knowledgeable professionals in the field of preventive holistic medicines. “The goal of this website is to educate people on various natural medical treatments and help […]

    Freely Available Standards to Help Ensure Quality of Medicines throughout the World

    Hyderabad:  To help ensure that medicines and their ingredients used around the world are of good quality, the United States Pharmacopeial Convention (USP) announced today the availability of a free, online collection of voluntary public standards to allow testing of a medicine and its ingredients. These standards appear in the new USP Medicines Compendium (MC). The MC […]

    Poor Oral Care May Cause Sexual Problems

    A recent study has revealed erectile dysfunction can be linked to gum disease. The research1, carried out on 70 male subjects, showed a correlation between gum disease and the ability to achieve an erection. The data indicates that as the severity of erectile dysfunction increased, so did the prevalence of chronic periodontitis (gum disease). Overall, […]

    India’s Themis Medicare, mPedigree, to Boost Patient Safety with Mobile Technology

    Mumbai: Themis Medicare, one of India’s leading research-based healthcare companies, and a pioneer in pharmaceutical innovation in emerging markets, has announced a new agreement with multiple award winning social enterprise, mPedigree Network, which shall see consumers of Themis’ life-saving drugs verifying the authenticity and quality status of their Themis’ brands for free via mobile phone […]

    13-Year-Old Boy Suffering From Rare Birth Defect Gets New Lease Of Life At Fortis Hospitals Bangalore

    Bengaluru: Fortis Hospitals Bangalore recently performed a complex and rare surgery on a 13-year-old boy from Bangalore who was suffering from an unusual birth defect. The patient, Balaji, was born with a condition known as Exstrophy-Epispadias Complex where the patient had an inability to contol his urination, due to an absent continence mechanism (which normally […]

    Wockhardt receives tentative US FDA approval for generic version of Patanol ophthalmic solution

    by NR Indran / INT Mumbai : Pharmaceutical and biotechnology major Wockhardt has received tentative approval from the United States Food & Drug Administration (US FDA) for marketing 0.1% solution of Olopatadine hydrochloride eye drops, which is used for allergic conjunctivitis. Olopatadine is the generic name for the brand Patanol®, marketed in the United States […]

    Max Bupa integrates with IGMS (IRDA system) in real time

    by NR Indran / INT Mumbai : Max Bupa Health Insurance has successfully integrated with IRDA’s ‘Integrated Grievance Management System’ in real time which makes it the first health insurance company in the country to have such a system in place. The integration will provide a platform for policy holders to easily access and log […]

    Schedule HX will make severe impact On availability of Antibiotics : J. S. Shinde

    by NR Indran / INT The recent move of Government of India to amend the Drugs & Cosmetics Rules 1945 and insert Schedule HX on misuse of antibiotics will not serve the purpose but will make severe impact on availability of Antibiotics in the 65% of rural & urban population. We as AIOCD appreciate the […]

    Fortis Completes a Decade in Healthcare

    by NR Indran / INT Mumbai : Fortis Healthcare (India) Ltd. marked a decade since the first hospital (Mohali) started, and kicked off celebrations across the country starting this week. Fortis has scripted a remarkable story these 10 years that of shaping a mammoth healthcare delivery organization with quality, patient-centricity and efficiency at its core. […]

    World Vision India urges Government to phase out Stavudine (d4T) drug as per WHO guidelines

    by NR Indran / INT Mumbai : World Vision India (WVI), at an interactive session here today urged the Government to immediately phase out Stavudine (d4T) from the first line regimen in tune with the World Health Organization (WHO) recommendation owing to its long term irreversible toxicities / side effects. Also WVI has urged NACO to […]